BMY

Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
$57.18
+0.27 (+0.47%)
Mkt Cap: 116.77B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield11.7%
Dividend YieldN/A
Market Cap116.77B
Volume9.58M
Recent News
Bristol Myers drug delays myeloma progression in hard to treat patients
reuters.com · 2026-05-29
How Bristol Is Building On Its $74 Billion Celgene Buyout With New 'Molecular Glue'
investors.com · 2026-05-29
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
businesswire.com · 2026-05-29
Bristol-Myers Squibb Is Quietly Building Its Next Growth Cycle
seekingalpha.com · 2026-05-27
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
businesswire.com · 2026-05-27
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
zacks.com · 2026-05-26

Unlock the Full Deep Scan

9 AI agents analyze BMY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →